Streetbeat News

Products Services

VTYX

Ventyx Biosciences (NASDAQ:VTYX) has completed patient enrollment for its Phase 2 trials of VTX002 in ulcerative colitis and VTX958 in plaque psoriasis.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:04 am

ABBV

AbbVie has announced that its schizophrenia treatment drug, VRAYLAR, will be reimbursed under the Non-Insured Health Benefits (NIHB) Program. This will make the drug more accessible to patients in need.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:03 am

COYA

Coya Therapeutics (NASDAQ:COYA) reported additional biomarker and brain imaging results from an open-label proof-of-concept clinical study for COYA 301 in patients with mild to moderate Alzheimer's Disease. The results will be presented on June 7th, 2023, at the LD Micro Conference in Los Angeles.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 11:03 am

FGEN

Fibrogen's Phase 3 Lelantos-1 trial of Pamrevlumab for non-ambulatory patients with Duchenne Muscular Dystrophy failed to meet the primary endpoint of Performance of the Upper Limb 2.0 score at week 52 compared to baseline.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 10:57 am

AMERICAN

Westwater Resources (NYSE:AMERICAN) has executed a letter of intent with Dainen Material for the supply and purchase of coated spherical purified graphite (CSPG) from its Kellyton Advanced Graphite Processing Plant.

Portfolio Pulse from Charles Gross

June 07, 2023 | 10:48 am

TFX

Teleflex has secured FDA clearance for its Wattson Temporary Pacing Guidewire, designed for use during TAVR and BAV procedures. The product will be featured at the TVT: The Structural Heart Summit and is expected to have a full market release later this year.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 10:31 am

GSK

The European Commission has approved GSK's Respiratory Syncytial Virus (RSV) vaccine for active immunization in adults aged 60 and older. This marks the first RSV vaccine for older adults to receive European Marketing Authorisation, with launches planned ahead of the 2023/2024 RSV season.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 10:16 am

COIN

Coinbase CEO Brian Armstrong is scheduled to appear on CNBC at 8:40 AM ET.

Portfolio Pulse from Charles Gross

June 07, 2023 | 10:06 am

DRRX

DURECT Corporation has completed enrollment in its Phase 2b AHFIRM clinical trial investigating larsucosterol for the treatment of severe alcohol-associated hepatitis, reaching its target of 300 patients.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2023 | 10:02 am

GOOG

GOOGL

SSNLF

Samsung's Galaxy Unpacked event will take place in Seoul for the first time, where the company is expected to unveil its latest foldable innovations, Galaxy Z Flip 5 and Z Fold 5. This comes after Google launched its inaugural foldable smartphone, Pixel Fold, in May.

Portfolio Pulse from Ananya Gairola

June 07, 2023 | 10:01 am